With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|MYC-driven Core Regulatory Circuits in Neuroblastoma||Dana-Farber Cancer Institute / Mark Zimmerman, PhD||Young Investigator Grants||2018||Massachusetts|
|Defining the Mechanism by which LIN28B acts as an Oncogene in Neuroblastoma||Children's Hospital of Philadelphia / Robert Schnepp, MD, PhD||Young Investigator Grants||2013||Pennsylvania|
|Immunotherapy Of Neuroblastoma With Natural Killer T Cells Engineered To Target O-acetyl-GD2||Baylor College of Medicine / Andras Heczey, MD||Young Investigator Grants||2014||Texas|
|Genetic Regulators of ER Stress-induced Apoptosis in Pediatric Malignancies||Dana-Farber Cancer Institute / Ujwal Pyati||Young Investigator Grants||2009||Massachusetts|
|The TC3 Line, a Zebrafish Model of T-Cell Malignancy||Huntsman Cancer Institute / Nathan Meeker, MD||Young Investigator Grants||2008||Utah|
|Single Cell Signaling Profiles In High-Risk Pediatric Leukemia||Stanford University / Kara Davis||Young Investigator Grants||2010||California|
|Investigating Racial Disparities in Pediatric Acute Leukemia||University of California San Francisco / Lena Winestone, MD||Young Investigator Grants||2016||California|
|Optimizing Engager T-cells for CD19+ Malignancies||Baylor College of Medicine / Mireya Paulina Velasquez, MD||Young Investigator Grants||2014||Texas|
|Targeting HMGA1 in Childhood ALL||The Johns Hopkins University School of Medicine / Amy M. Belton, PhD||Young Investigator Grants||2011||Maryland|
|Targeting the Thymic Stromal Lymphopoeitin Receptor Signaling Axis to Reduce Relapse of High Risk Pediatric Acute Lymphoblastic Leukemia||National Cancer Institute / Christopher Chien, PhD||Young Investigator Grants||2014||Maryland|